Heptaminol
WikiDoc Resources for Heptaminol |
Articles |
---|
Most recent articles on Heptaminol |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Heptaminol at Clinical Trials.gov Clinical Trials on Heptaminol at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Heptaminol
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Heptaminol Discussion groups on Heptaminol Patient Handouts on Heptaminol Directions to Hospitals Treating Heptaminol Risk calculators and risk factors for Heptaminol
|
Healthcare Provider Resources |
Causes & Risk Factors for Heptaminol |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Heptaminol is an amino alcohol which is classified as a vasodilator (C01DX08 (WHO)). It is sometimes used in the treatment of low blood pressure, particularly orthostatic hypotension. It is a potent positive inotrope (improving cardiac contraction) It is classified as a doping substance. In 2008, the cyclist Dmitriy Fofonov was tested positive at the Tour de France.[1] In June 2010, the swimmer Frédérick Bousquet was tested positive for the substance, allegedly for buying a medicine from the pharmacy.[2] In 2013, the cyclist Sylvain Georges was tested positive at the Giro d'Italia.[3] In 2014, baseball player Joel Piniero tested positive. [4]
See also
References
- ↑ "Tour rider Fofonov tests positive". BBC. 2008-07-28. Retrieved 2008-07-28.
- ↑ "France swimmer Bousquet suspended in doping scandal". France24. 2010-10-24. Retrieved 2010-10-23.
- ↑ "UCI notifies French rider Sylvain Georges of positive doping test at the Giro". The Associated Press. 2013-05-15. Retrieved 2013-05-15.
- ↑ "Joel Pineiro suspended 50 games". ESPN. 2014-06-30. Retrieved 2014-06-30.